DNV  Capital

Developing New Value

DNV  Capital

Developing New Value

Introduction

DNV Capital, is an international venture capital firm focusing on the investments in healthcare and innovative technology industry.

DNV Capital concentrates on venture capital investment in start-up period and growth period, the directions of investment cover: medical treatment and health industry (including technology-leading pharmaceutic preparations, biological products, medical equipment and medical facilities; market-leading medical care providers, tele-medicine and health management) and innovative technology industry (including artificial intelligence (AI), Internet of Things, high-end robot, 3D printing, sensor and cloud computing).

DNV Capital is honored to be the member of Shenzhen Private Equity Association and Zhongguancun Private Equity& Venture Capital Association.

Team

Managing Partner

Kevin Lin

Partner

Frank Wang

Partner

Zhe Yang

Partner

Joyce Lv

Portfolio

News

Sinovation has D+ round of financing, DNV Capital, as an existing shareholder, further increased its investment

Sinovation has D+ round of financing, DNV Capital, as an existing shareholder, further increased its investment.

DNV Capital proudly received the "Top 30 Growing Investment Institutions in China for 2023" award.

DNV Capital proudly received the "Top 30 Growing Investment Institutions in China for 2023" award.

DNV Capital and ZTE Group Jointly Establish the [Denuowei] Series of Funds

In December 2021, DNV Capital, in collaboration with ZTE Weixiantong, officially established the [Denuowei] series of funds.